3D cell culture is a process in which the cells can grow in an artificially created environment. These environments nearly resemble the structure and functioning of the native tissue. 3D cell culture method helps enhance cell differentiation, escalation and migration by interacting with their three-dimensional surroundings as they would in the in-vivo environment. The high usage of 3-dimensional models for research about Covid-19 and respiratory diseases is anticipated to provide vital growth opportunities to the market. On the other hand, the dearth of infrastructure for 3d cell-based research is likely to hamper the market growth. The 3D cell cultures are mostly applicable in studies that need in vivo model systems to examine the impact of a foreign drug over body tissues and organs. Additionally, biomimetic tissue constructs utilized to produce 3D organotypic structures host a large number of research entities to adopt 3-dimensional cell culture techniques.
Request for a sample report: https://whipsmartmi.com/sample/md0538/3D-Cell-Culture-Market
Key Driving Factors: Growing Focus on Developing Alternatives to Animal Testing
The growth of the 3D cell culture market is driven by the development of alternatives to animal testing by leading vendors. Since, using animals for testing and research has given rise to ethical issues being highlighted by animal welfare organizations. According to the Humane Society International in 2019, 115 million animals were used for animal testing, across the world, every year. Hence, the 3D cell culture is projected to replace the animals for testing in laboratories. Therefore, the government and non-profit organizations such as the National Toxicology Program, The Environmental Protection Agency and the National Institutes of Health introduced the ToxCast initiative, amongst others, to replace laboratory animals with 3D cell culture which is a key factor to accelerate the 3D cell culture market.
Merck KGaA (Sigma-Aldrich Corporation), Corning Incorporated, Becton.Dickinson and Company, Lonza Group., Thermo Fisher Scientific, Inc., 3D Biotek LLC., InSphero AG., Nanofiber Solutions, Inc and Greiner Group A are the few notable companies of the 3D cell culture market.
Opportunities: Introduction of microfluidics in 3D cell culture will generate opportunities for the 3D cell culture market
The microfluidic technology has unlocked a bunch of opportunities for the 3D cell culture market by developing a platform which can generate a cell culture model, which replicates human organs. The microfluidic technology has several benefits over the conventional method. Microfluidic devices can create complex dynamic micro-scale environments which resemble in-vivo environments. It also minimizes the cost of drug discovery by decreasing the need for samples and reagents.
Market Based on End Users
The major end users included in the 3D cell culture market are pharmaceutical & biotechnology companies, research institutes, cosmetics industry, other end users and other products. The academic institutes segment commanded the 3D cell culture market. The significant growth is ascribed to increase in collaborations among academic institutions and biotechnology & pharmaceutical companies around the world. Various companies merging with laboratories for performing primary research to finally minimize the overall time required for the completion of the research. Contract research laboratories segment is projected to grow rapidly by 2027 over the forecast period, due to the increased requirement to offer diagnostic services to biopharmaceutical companies and research laboratories for performing research activities.
By End User
Access to Full Report Summary: https://whipsmartmi.com/Report/3D-Cell-Culture-Market
Published Date : March-2021